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Estrogen and hippocampal synaptic plasticity
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During the past several years, there has been increasing interest in the effects of estrogen on neural function. This enthusiasm is
driven, in part, by the results of early clinical studies suggesting that estrogen therapy given after menopause may prevent, or at
least delay, the onset of Alzheimer’s disease in older women. However, later clinical trials of women with probable Alzheimer’s
disease had contrary results. Much of the current research related to estrogen and brain function is focused in two directions. One
involves clinical studies that examine the potential of estrogen in protecting against cognitive decline during normal aging and
against Alzheimer’s disease (neuroprotection). The other direction, which is the primary focus of this review, involves laboratory
studies that examine the mechanisms by which estrogen can modify the structure of nerve cells and alter the way neurons com-
municate with other cells in the brain (neuroplasticity). In this review, we examine recent evidence from experimental and
clinical research on the rapid effects of estrogen on several mechanisms that involve synaptic plasticity in the nervous system,
including hippocampal excitability, long-term potentiation and depression related to sex and aging differences, cellular
neuroprotection and probable molecular mechanisms of the action of estrogen in brain tissue.
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Long-term potentiation
Long-term potentiation (LTP) of synaptic transmission in
hippocampus and neocortex is considered to be a cellular
model of memory trace formation in the brain, at least for
certain forms of memory (Landfield and Deadwyler, 1988;
Bliss and Collingridge, 1993; Baudry et al., 2000). The large
body of work on the molecular and synaptic mechanisms
underlying LTP (Bear and Malenka, 1994; Geinisman, 2000) is
matched by a growing number of studies suggesting the critical
role of LTP in behavioral learning and memory (Shors and
Matzel, 1997; Morris et al., 2003). Regardless of whether LTP is
the substrate of the synaptic modifications that occur during
learning in forebrain structures of vertebrates, studies of its
mechanisms have revealed several processes that undoubtedly
play crucial roles in memory formation (Bi and Poo, 2001).
In area CA1 of the hippocampus, the most widely studied
form of LTP requires glutamate NMDA receptor activation
for its induction, and an increase in AMPA receptor function
for its expression and maintenance. In addition, Teyler and
associates have demonstrated a second form of tetanus-
induced LTP in CA1 that is independent of NMDA receptors,
and involves voltage-dependent calcium channels (Grover and
Teyler, 1990).
Estrogen and cognition
A small, but growing animal literature indicates that 17b-
estradiol, the most potent biologically relevant estrogen,
facilitates some forms of learning and memory, particularly
for hippocampal-dependent tasks. A post-training injection
of 17b-estradiol facilitates retention in the Morris water maze
(Singh et al., 1994), and a cholinergic agonist enhanced this
effect (Packard and Teather, 1997). In another series of studies,
the effects of 17b-estradiol and raloxifene (a selective estrogen-
receptor modulator) have been evaluated on the acquisition
of a delayed matching to position in a T-maze task and on
hippocampal acetylcholine release in ovariectomized rats. The
results show that 17b-estradiol, but not raloxifene, enhances
the T-maze-task performance, and that 17b-estradiol and a
high dose of raloxifene increase potassium-stimulated acetyl-
choline release in the hippocampus (Gibbs et al., 1994). By
contrast, some studies find little or no effect of the estrous cycle
(and thereby of endogenous levels of 17b-estradiol) on tasks
involving spatial memory (Galea et al., 1995; Berry et al., 1997;
Warren and Juraska, 1997; Woolley, 1998).
In humans, the depletion of estrogen that occurs after
the menopause increases the susceptibility of women to
Alzheimer’s disease (Paganini-Hill and Henderson, 1996),
whereas estrogen replacement in postmenopausal women
improves verbal memory (Asthana et al., 2001; Resnick and
Maki, 2001). Healthy postmenopausal women with estrogen
replacement scored significantly higher on tests of immediate
and delayed paragraph recall compared with healthy post-
menopausal women not taking estrogen replacement
(Kampen and Sherwin, 1994). Other evaluations of estrogen-
replacement therapy in Alzheimer’s disease patients indicate
that estrogen does not alleviate cognitive impairment associ-
ated with the disease (Mulnard et al., 2000) but it does seem to
have a beneficial effect as a preventive treatment (Tang et al.,
1996), which is most apparent in younger, postmenopausal
women (Henderson et al., 2005).
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Estrogen activation and the brain
The nervous system is a major target of hormones and contains
receptors specific for many types of steroid hormones, includ-
ing estrogen, aldosterone, androgen and corticosterone. Cell-
fractionation studies that examine 17b-estradiol binding in
cytosolic and nuclear fractions show that estradiol–receptor
complexes are translocated from the cytosol to the nuclear
fraction of cells. Once in the nucleus, the estradiol–receptor
complex exerts its effect via alterations in gene transcription,
followed by changes in protein synthesis. This constitutes the
classic genomic mechanism of action for several steroid recep-
tors that interacts with and alters DNA transcription and gene
expression. This process is characterized by a long latency
and duration of action on the scale of hours to days. Many
of the effects of estrogen and other hormones in the brain
are explained readily by this genomic mechanism of action
(McEwen and Alves, 1999).
In contrast to the genomic mechanism described above,
several steroid hormones have been found to produce rapid,
short-term effects, which affect mostly electrophysiological
properties of neurons, with latency and duration on the scale
of milliseconds to minutes. Because activation of transcrip-
tional and translational mechanisms by intracellular steroid-
hormone receptors requires a longer latency, physiological
responses occurring with extremely short latencies have been
presumed to involve nongenomic, specific membrane actions.
Estrogen and hippocampal electrophysiology
For more than 30 years, electrophysiological reports have
shown estrogen to promote changes in synaptic excitability
and plasticity within the nervous system. In a pioneering study,
decreased thresholds for hippocampal seizures were found in
animals primed with estrogen and during proestrus, the time
of the estrus cycle when estrogen levels are highest (Terasawa
and Timiras, 1968). In humans, changes in electrical activity
of nervous system tissue correlate with hormonal factors that
appear to play a role in catamenial epilepsy, a form of epilepsy
in which the likelihood of seizures varies during the menstrual
cycle. Many women with catamenial epilepsy experience a
sharp increase in seizure frequency immediately before
menstruation, when estrogen concentrations relative to those
of progesterone are also at their highest levels (Backstrom,
1976). Changes in hippocampal responsiveness that correlate
with estrogen activity have been reported in a study that found
that induction of LTP is maximal in female rats during the
afternoon of proestrus, when endogenous estrogen concentra-
tions are highest (Warren et al., 1995). Furthermore, ovari-
ectomized rats treated with estrogen have a facilitation for
the induction of hippocampal LTP (Cordoba Montoya and
Carrer, 1997).
Estrogen and hippocampal excitability
The development of in vitro models to study the mechanisms
of neuronal plasticity allow researchers to investigate how
estrogen regulates synaptic excitability in the nervous system,
and, in particular, the hippocampus. However, the binding of
tritiated estradiol in the hippocampus does not approach that
seen in the hypothalamus and related diencephalic structures
(McEwen et al., 1975; McEwen and Alves, 1999). Nonetheless,
studies by Teyler and colleagues using in vitro hippocampal
slice preparations have shown that gonadal steroids drama-
tically affect neuronal excitability in specific pathways of
the rodent hippocampus (Teyler et al., 1980; Vardaris and
Teyler, 1980). In initial experiments, extracellular monosynap-
tic population field responses recorded from area CA1 of
hippocampal slices from male and female rats were monitored
before and after the application of 17b-estradiol (100 pM)
to the slice incubation medium (artificial cerebrospinal
fluid; aCSF). In male rats, 17b-estradiol produced a rapid
(<10 minute) enhancement of population field responses
evoked by stimulation of the afferents to CA1 pyramidal cells
(Fig. 1). This was the first published report to demonstrate that
picomolar concentrations of the gonadal steroid 17b-estradiol
directly enhanced glutamatergic synaptic transmission in
hippocampus (Teyler et al., 1980).
Fig. 1. Hippocampal slice preparation. (A) Diagram of a transverse
hippocampal slice. Stimulating electrodes are located in the afferent pathway,
which contains the Schaffer (Sch) collaterals. Recording micropipettes are
situated in the pyramidal cell body layer in CA1. Cells of this subfield receive
monosynaptic input from the CA3 pyramids via the Sch collateral system.
(B) Representative field potentials from slice preparations in various
experimental conditions. Extracellular population-spike responses to a given
stimulus intensity are shown from the control period (before steroid
administration) and after the administration of either 10−10 M 17b-estradiol (E)
or 10−10 M testosterone (T). Potentials from slices from males and proestrus
and diestrus females are shown for comparison. All potentials are single
sweeps recorded at the same voltage and time scales. (C) Summary of the major
experimental outcomes. Values on the ordinate are mean percentages of
spike amplitudes after steroid administration. Data (mean ± S.E.M.) for each
condition are from 6–10 animals, each contributing one slice. Reprinted, with
permission, from Teyler et al. (1980).
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Estrogen and nongenomic mechanism of
action
Although the genomic mechanism of action of estrogen is the
traditional framework for interpreting the mechanisms of
the effects of estrogen on cell function, an increasing number
of reports document the effects of acute applications of estro-
genic steroids that are too rapid (occurring in <10 minutes) to
be accounted for exclusively by a genomic pathway. In particu-
lar, the existence of rapid estrogenic steroid-induced changes
in neuronal excitability indicates that other, nongenomic
mechanisms that involve direct interactions with sites on the
plasma membrane either alter or regulate several ion channels
and neurotransmitter transporters (Pfaff and McEwen, 1983;
Wong et al., 1996). Although the mechanism of action of
gonadal steroids in the hippocampus is not understood
entirely, there is reason to believe that it is receptor-mediated.
There is no facilitation of the field responses when the inactive
estrogen 17a-estradiol is added to the hippocampal slice
medium (Foy and Teyler, 1983), and the further addition
of 17b-estradiol no longer results in an increased response,
as observed in the presence of 17b-estradiol alone (Foy and
Teyler, 1983; Wong and Moss, 1991; Wong and Moss, 1992).
Similar results were found when the estrogen receptor
antagonist tamoxifen is applied to hippocampal slices before
addition of 17b-estradiol (Foy, 1983). The ability of 17a-
estradiol and tamoxifen to block the effects of 17b-estradiol on
hippocampal excitability provides strong evidence that the
rapid physiological modulation of gonadal hormones is most
likely to be caused by a plasma-membrane, receptor-
mediated phenomenon.
Estrogen and AMPA receptor activation
In vitro intracellular recordings of CA1 neurons from adult
ovariectomized female rats have shown that the administra-
tion of 17b-estradiol increases synaptic excitability, in part, by
enhancing the magnitude of a-amino-3-hydroxy-5-methyl-4-
isoxazoleproprianate (AMPA) receptor-mediated responses
(Wong and Moss, 1992). The rapid onset of this increased
excitability and its blockade by 6-cyano-7-nitroquinaxaline,
an AMPA receptor antagonist) but not by D-2-amino-
5-phosphonovalerate (D-APV), a competitive N-methyl-
D-aspartate (NMDA) receptor antagonist, supports a
postsynaptic membrane site of action that is most likely to be
mediated by non-NMDA glutamate receptors. Later studies
using whole cell recordings found that acute 17b-estradiol
application potentiated kainate-induced currents in a sub-
population of CA1 cells (Gu and Moss, 1996), but a direct
interaction between 17b-estradiol and the receptor channel
was not indicated (Wong and Moss, 1994).
Fig. 2. Fast potentiation by 17b-estradiol perfusion of pharmacologically
isolated, non-NMDA-receptor-mediated EPSPs. The AMPA receptor was
isolated pharmacologically by applying the NMDA-receptor antagonist
D-APV (50 µM) and the GABA-receptor antagonist bicuculline (5 µM) to the
bath. (A) 1 nM 17b-estradiol potentiates non-NMDA-mediated EPSPs in aCSF
containing D-APV and 1.0 mM Mg2+. (B) Some cells showed action potentials
during continuous perfusion with 17b-estradiol but not in control conditions
(before 17b-estradiol perfusion). Reprinted, with permission, from Foy et al.
(1999).
Fig. 3. EPSPs in CA1 pyramidal cells. The amplitude of NMDA-
receptor-mediated EPSPs in CA1 pyramidal cells increases shortly after
addition of 1 nM 17b-estradiol to the perfusion medium, which contains 5 µM
bicuculline. (A) Top: EPSPs evoked when slices are perfused with medium
that includes 1.0 mM Mg2+ but not the non-NMDA receptor antagonist 6,7-
dinitroquinoxaline-2,3-dione (DNQX). Bottom: NMDA-receptor-mediated
EPSPs evoked 10 minutes after medium was switched to include 0.1 mM
Mg2+ and 10 µM DNQX. (B) 1 nM 17b-estradiol potentiates the isolated
EPSPs within 3 minutes. Potentiation, which occurred in 9 out of 12 cells, was
observed in EPSPs evoked by paired-pulse stimulation and peaked within
10 minutes. In 5 out of 9 cells, the potentiated EPSPs reached threshold and
generated action potentials during 17b-estradiol perfusion. The potentiated
EPSPs were blocked by the NMDA receptor antagonist D-APV. Reprinted,
with permission, from Foy et al. (1999).
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An example of this effect from our work (Fig. 2) shows
intracellular recordings of excitatory post-synaptic potentials
(EPSPs) from a CA1 pyramidal neuron in hippocampal slices
from an adult male rat in response to brief depolarizing pulses
separated by 67 mseconds in a medium containing 50 µM
D-APV and 1.0 mM Mg2+ (to block NMDA receptors). There is
a rapid, dramatic increase in EPSP amplitude within 4 minutes
of 17b-estradiol infusion, and some cells exhibit depolariza-
tion-induced action potentials within 8 minutes of infusion
(Foy et al., 1999).
Estrogen and NMDA receptor activation
A large body of evidence demonstrates that regulation of
synapse formation by 17b-estradiol is dependent on NMDA
receptor activation. Morphological studies of neurons in cul-
ture prepared from embryonic-day-18 rat embryos show that
estrogenic steroids exert a growth-promoting, neurotrophic
effect on hippocampal and cortical neurons by a mechanism
that requires activation of NMDA receptors (Brinton et al.,
1997a; Brinton et al., 1997b). Studies in vivo using adult ovari-
ectomized female rats also reveal an increased number of
dendritic spines in hippocampal CA1 pyramidal cells after
17b-estradiol treatment, which is prevented by blockade of
NMDA receptors but not by AMPA receptor and muscarinic
receptor antagonists (Woolley and McEwen, 1994). Other
reports using adult ovariectomized female rats provide
evidence that chronic treatment with 17b-estradiol increased
the number of NMDA receptor-binding sites and NMDA
receptor-mediated responses (Gazzaley et al., 1996; Woolley
et al., 1997). These studies indicate that estrogen and NMDA
receptors are heavily involved in synapse formation.
Estrogen and NMDA receptor-mediated EPSPs
The possibility that 17b-estradiol might directly regulate
NMDA receptor-mediated synaptic transmission might not
have been detected previously (e.g., Wong and Moss, 1992)
because tests of this hypothesis were not conducted under
optimal conditions. Because of the voltage-dependent block-
ade of the NMDA receptor channel by Mg2+ and the slow
kinetics of the channel opening relative to that of the AMPA
receptor, NMDA receptor stimulation mediates only a minor
component of the excitatory postsynaptic potential (EPSP)
evoked by low-frequency stimulation of glutamatergic affer-
ents. This NMDA receptor component is enhanced by either
low Mg2+ concentrations or using high-frequency stimulation
patterns to induce the depolarization accompanying the sum-
mation of overlapping EPSPs (Xie et al., 1992). In experiments
using low Mg2+ concentrations and in the presence of the
AMPA receptor antagonist 6,7-dinitroquinoxaline-2,3-dione
(DNQX), acute application of 17b-estradiol in hippocampal
slices from adult male rats results in a rapid increase in the
amplitude of NMDA receptor-mediated EPSPs evoked by
Fig. 4. Field EPSP (f-EPSP) recordings in area CA1. (A) All hippocampal slices were perfused with aCSF for 10 minutes to obtain f-EPSP slope and amplitude
percentage baseline data. After 10 minutes of baseline recording, experimental slices were perfused with 100 pM 17b-estradiol. Control slices continued to be
perfused with aCSF. 30 minutes later all slices received high-frequency stimulation, designed to induce LTP.  (A1) fEPSP recording at the end of the 10-minute
baseline period. (A2) fEPSP recording at the end of the 30-minute perfusion with 17b-estradiol. (A3) fEPSP recorded for 30 minutes after high-frequency
stimulation in slices perfused with 17b-estradiol. (B) fEPSP slope responses in area CA1. Data points represent averaged fEPSP slope ± S.E. (taken at each 20-second
sweep) for experimental (17b-estradiol-treated) and control (aCSF) hippocampal slices. Reprinted, with permission, from Foy et al. (1999).
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stimulation of Schaffer collaterals (Foy et al., 1999). The effect
of 17b-estradiol on pharmacologically isolated NMDA recep-
tor-mediated synaptic responses is such that concentrations of
17b-estradiol >10 nM induce seizure activity in hippocampal
neurons, and lower concentrations (1 nM) markedly increase
the amplitude of NMDA receptor-mediated EPSPs (Fig. 3).
Estrogen and hippocampal LTP
To investigate the effect of estrogen on synaptic plasticity
associated with learning and memory function, estrogen was
applied to hippocampal slices from adult male rats before
exposure to high-frequency stimulation designed to induce
LTP. When LTP was assessed after high-frequency stimu-
lation, fEPSP values increased significantly in 17b-estradiol-
treated slices compared with control, aCSF slices (Fig. 4). The
mean increases in the slope of fEPSP was 192% (experimental)
compared with 154% (control). Thus, hippocampal slices from
adult male rats treated with 17b-estradiol exhibited a pro-
nounced, persistent, significant increase in LTP, measured by
both population fEPSP slope and fEPSP amplitude recordings
(Foy et al., 1999).
To further evaluate the effects of 17b-estradiol on the mag-
nitude of hippocampal LTP, the intensity of afferent stimula-
tion to Schaffer collaterals in slices perfused with 17b-estradiol
was decreased to produce baseline values similar to pre-17b-
estradiol responses immediately before delivery of the high-
frequency stimulation train used to elicit LTP (Bi et al., 2000).
Under these conditions, 17b-estradiol still increased the ampli-
tude of LTP from adult male rat hippocampal slices compared
with control (aCSF) slices (Fig. 5). These findings, along with
other results from this study, indicate that the estrogen-
induced enhancement of hippocampal LTP is not caused
simply by a change in basal EPSP level, but is more likely to
result from biochemical activation of an intracellular cascade,
which, presumably, is mediated by activation of a src tyrosine
pathway that enhances NMDA receptor function.
Estrogen and hippocampal LTP in females
In another series of studies, estrous-cycle changes in rodents
have been correlated with changes in synaptic plasticity.
Hippocampal slices from cycling female rats in diestrus (low
estrogen concentration) and proestrus (high estrogen concen-
tration) were prepared and recorded in aCSF, followed by LTP
induction via high-frequency stimulation. The difference in
LTP values between these groups following high-frequency
stimulation was dramatic: slices from rats in the proestrus
phase exhibited LTP representing ~50% increase over baseline,
whereas slices from rats in the diestrus phase had LTP values
Fig. 5. Effects of src inhibition on 17b-estradiol (E2)-mediated enhancement of EPSP amplitude and degree of LTP in hippocampal slices. A stimulating
electrode was located in CA3 and a recording electrode in the stratum radiatum of CA1. Extracellular EPSPs were evoked by stimulation every 30 seconds, and the
EPSP amplitude measured. After recording a stable baseline, an inhibitor of src (PP2, 10 µM) and E2 (1 nM) were added at the times indicated. After resetting the
stimulation intensity to obtain EPSPs of the same amplitude as before treatment with either PP2 or E2, high-frequency stimulation (HFS) was delivered, and low-
frequency stimulation resumed. PP2 blocked the estrogen-mediated enhancement of LTP but did not affect LTP itself. Data (expressed as percentages of predrug
values) are mean ± S.E.M. of 6–10 experiments. Reprinted, with permission, from Bi et al. (2000).
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representing ~25% increase over baseline (Bi et al., 2001)
(Fig. 6). These findings help to support the results from the
original work of Teyler et al. (1980), who identified changes
in baseline synaptic transmission that correlated with the
phase of the estrus cycle in female rats at the time of
hippocampal-slice preparation.
The electrophysiological study above shows that female rats
in proestrus have an increased magnitude of hippocampal LTP
compared with female rats in diestrus. Here we report a cur-
rent study that examines the effect of 17b-estradiol on hippo-
campal LTP during the same crucial time periods in the rat
estrous cycle: proestrus and diestrus. The estrous cycles of
adult (3–5 month) Sprague-Dawley rats were monitored for
10 days before physiological experiments, and hippocampal
slices were prepared from rats in either proestrus or diestrus.
Recording and stimulating electrodes were positioned in the
dendrites of area CA1 and Schaffer collaterals, respectively.
Baseline stimulation (0.05 Hz, 100 µsec) was adjusted to elicit
50% of the maximum fEPSP amplitude. After 10 minutes of
stable baseline stimulation, slices were perfused for 30 minutes
with either aCSF or 17b-estradiol (100 pM; experimental
group) and LTP induced by a brief period of high-frequency
stimulation (5 trains of 20 pulses at 100 Hz). Subsequent
synaptic responses were monitored for 30 minutes post-LTP
induction. LTP induced in area CA1 was greater in slices from
proestrus rats compared with slices from diestrus rats, as seen
previously (Bi et al., 2001). However, 17b-estradiol treatment
increased LTP in slices from diestrus rats, but decreased LTP in
slices from proestrus rats (Fig. 7). These observations indicate
that 17b-estradiol alters hippocampal LTP in female rats
depending on the state of their estrous cycle (i.e. on the levels
of circulating 17b-estradiol). In cycling female rats, when
endogenous circulating levels of 17b-estradiol are at their
highest levels (proestrus), LTP magnitude is increased and
exogenously applied 17b-estradiol decreases LTP magnitude,
possibly through the activation of a mechanism that is
associated with either an inhibitory or ceiling effect. When
endogenous circulating levels of 17b-estradiol are at their
lowest levels (diestrus), the situation is reversed from that
observed in the proestrus state. Here, LTP magnitude is
decreased, and exogenously applied 17b-estradiol increases
LTP magnitude.
These results indicate that the cyclic changes in estrogen
levels occurring during the estrous cycle in female rats are
associated with changes in the magnitude of LTP recorded
from hippocampal CA1 cells, and corroborate work
mentioned earlier indicating that estrogen facilitates LTP
induction in ovariectomized female rats (Cordoba Montoya
Fig. 6. LTP in field CA1 of hippocampal slices from female rats in proestrus and diestrus. Hippocampal slices from female rats in either proestrus or diestrus were
prepared. fEPSP amplitude and slope values were obtained for each slice and averaged across slices to produce one mean before and after the train of high
frequency stimulation (hfs). fEPSP amplitudes and slopes were normalized for the 10-minute pre-hfs period for each slice. ANOVA and planned two-tailed t tests
for pre-hfs and post-hfs periods were used to evaluate the effects of estrous on fEPSP slope and amplitude. (A) Representative waveforms from female rats in
proestrus and diestrus for pre-hfs (1) and post-hfs (2) periods. (B) Mean ± S.E.M. of fEPSP slopes recorded in slices from female rats in proestrus (filled circles,
n = 6) and diestrus (open circles, n = 5). Reprinted, with permission, from Bi et al. (2001).
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and Carrer, 1997), and that LTP increases in the afternoon of
proestrus of female rats (Warren et al., 1995).
Estrogen, LTP, LTD and aging
It is reported that when memory function declines in aging, the
processes of synaptic plasticity in the hippocampus are altered.
Specifically, LTP is impaired and the opposite process of long-
term depression (LTD) is enhanced (Landfield and Lynch,
1977; Barnes, 1979; Landfield et al., 1986; Barnes et al., 1992;
Barnes, 1994; Geinisman et al., 1995; Norris et al., 1996; Foster
and Norris, 1997; Norris et al., 1998; Foster, 1999). We repli-
cated this effect of aging on LTD and discovered a profound
action of estrogen on this process in aged male rats (Vouimba
et al., 2000). LTD was induced in the CA1 region of hippocam-
pal slices using standard conditions (potentiation of Schaffer
collaterals at 1 Hz for 15 minutes) in adult (3–5 month) and
aged (18–24 month) Sprague-Dawley male (?) rats. In agree-
ment with earlier studies, we found that the standard protocol
for inducing LTD caused little or no LTD in slices from adult
animals, but in marked LTD in slices from aged animals
(Fig. 8A) (Foster and Norris, 1997; Foster, 1999). Infusion of
slices with 17b-estradiol caused a slight increase in baseline
synaptic transmission, as in previous studies. It had little effect
on LTD in slices from adult animals, but markedly attenuated
LTD in slices from aged animals (Fig. 8B). Thus, prevention
by estrogen of the age-related enhancement of LTD might
account, in part, for the protective effects reported in some
studies of estrogen on memory functions in aged organisms
(see below).
Estrogen and two forms of LTP
As noted earlier, Teyler and associates discovered a form of
LTP in CA1 pyramidal neurons that is independent of NMDA
receptors and involves voltage-dependent calcium channels
(Grover and Teyler, 1990). This form of LTP is induced most
strongly by a very high frequency tetanus of Schaffer collaterals
(e.g. 200 Hz for 1 second) and is blocked by nifedipine but
not by the NMDA receptor antagonist D-APV. The NMDA
receptor-dependent form of LTP in CA1, which also involves
calcium influx via NMDA receptor channels, is induced best
by lower frequencies of tetanic stimulation (e.g. 25 Hz) and is
blocked by D-APV but not by nifedipine. The standard tetanus
for LTP induction (100 Hz for 1 second) induces both forms of
LTP (Cavus and Teyler, 1996; Morgan et al., 2001).
In current work in progress, we are exploring the effects of
acute application of 17b-estradiol on both forms of LTP in CA1
hippocampal slices from male rats. Using a 25 Hz tetanus of
Schaffer collaterals, 17b-estradiol and nifedipine were infused
and extracellular field EPSPs recorded. 17b-estradiol causes the
expected increase in synaptic transmission and pronounced
enhancement of LTP, but nifedipine has no effect on either
process, implying that, under this condition, LTP is mostly
dependent on NMDA receptor activation and estrogen facili-
tates LTP by increasing NMDA receptor-dependent function
(Zeng et al., 2004).
Using a 100 Hz tetanus of Schaffer collaterals in the CA1
region of hippocampal slices from adult male rats, we have
recorded both extracellular field EPSPs and intracellular
EPSPs from pyramidal neurons and infused 17b-estradiol and
nifedipine. 17b-estradiol alone causes the expected increase in
synaptic transmission and pronounced enhancement of LTP,
but both effects of 17b-estradiol are reduced in magnitude
by nifedipine. Therefore, under this condition, it seems that
17b-estradiol acts by modulating both L-type voltage-gated
calcium channels and NMDA receptors. Intracellularly
recorded EPSPs in response to paired subthreshold stimuli
with a short interstimulus interval (50 msecond) in the pres-
ence of 17b-estradiol indicates an increase in EPSP amplitude
to both stimuli without changes in the paired-pulse ratio,
which strongly supports a postsynaptic origin of the effects of
17b-estradiol (Akopian et al., 2003).
The possibility that 17b-estradiol modulates calcium influx
through L-type calcium channels is consistent with the effects
of aging on synaptic transmission and plasticity in hippo-
campus. Thus, aging is associated with enhanced activity of
voltage-gated calcium channels in hippocampal CA1 neurons
(Campbell et al., 1996), and blocking calcium influx through
L-type calcium channels inhibits LTD induction and enhances
LTP in aged animals in the CA1 region of hippocampal slices
(Norris et al., 1998). Blocking L-type calcium channels in the
Fig. 7. LTP in field CA1 of hippocampal slices from female rats in proestrus
and diestrus during treatment with 17b-estradiol (experimental) and aCSF
(control). (A) Mean ± S.E.M. of fEPSP amplitudes recorded following tetanus
in slices from female rats in diestrus. 17b-estradiol (filled circles) enhances LTP
relative to control aCSF (open circles). (B) Mean ± S.E.M. of fEPSP amplitudes
recorded following tetanus in slices from female rats in proestrus. 17b-estradiol
(filled circles) impaired LTP relative to control aCSF (open circles).
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Fig. 8. Long-term depression. (A) Normalized fEPSP amplitudes (percentage
of baseline) obtained in slices from adult (filled circles, n = 11) and aged (open
circles, n = 8) rats bathed in normal perfusion media (aCSF). After an initial
baseline period, low-frequency stimulation (LFS) induced robust LTD in slices
from aged rats, but not adult rats. The horizontal bar indicates when 900 pulses
at 1 Hz were delivered. (B) Effect of 17b-estradiol on LTD in slices from aged
and adult rats. Before addition of 17b-estradiol, fEPSP amplitudes recorded
during the baseline period were similar in both control and experimental
groups. LFS delivered to slices from aged rats perfused with 17b-estradiol (open
circles, n = 6) did not induce robust LTD. Following LFS, slices from adult rats
displayed little change in their synaptic response in the presence of 17b-
estradiol (filled circles, n = 6) compared with their control (aCSF). Reprinted,
with permission, from Vouimba et al. (2000).
hippocampus is also reported to enhance memory in several
paradigms and, particularly, to enhance learning and memory
processes in aged animals (Quevedo et al., 1998; Power et al.,
2002; Disterhoft et al., 2004).
Estrogen and cellular neuroprotection
In a well-established model of estrogen-induced neuro-
protection, primary cultures of dissociated hippocampal
neurons are prepared in medium that contains the excitatory
amino acid, glutamic acid. Neuronal injury in the cell cultures
resulting from glutamate excitotoxicity is assessed by quantify-
ing the release of lactate dehydrogenase into the culture
medium. A 5-minute treatment with 100 µM glutamate caused
significant cell death compared to control conditions (no
glutamate exposure), an effect that decreased significantly
following pre-exposure to 17b-estradiol (Nilsen and Brinton,
2002a).
In another in vitro study using microfluorimetry and
calcium imaging techniques in primary cultures of dissociated
hippocampal neurons, 17b-estradiol potentiates the
glutamate-induced increase in intracellular calcium by ~70%
compared with glutamate exposure alone (Nilsen and Brinton,
2002b). The estrogen enhancement of this glutamate response
agrees with other reports showing enhancement of NMDA
receptor activation, LTP and memory by estrogens (Foy et al.,
1999; Rice et al., 2000). Estrogen-induced neuroprotection
against excitotoxic glutamate may involve the mitogen-
activated protein (MAP) kinase cascade in primary cultures of
cortical neurons (Singer et al., 1999; Nilsen and Brinton, 2003).
The impact of estrogen on cellular neuroprotection is specific
and dramatic. However, the mechanisms involved in these
actions need to be elucidated further to comprehend the
complex and indirect ways in which estrogen interacts with
cellular signaling pathways.
Molecular mechanisms of the effects of
estrogen in brain
Recent results from several laboratories provide a general
framework to understand the mechanisms underlying the
multiple effects of 17b-estradiol on synaptic structure and
function (Lee and McEwen, 2001). At physiological concentra-
tions, 17b-estradiol interacts with estrogen receptors (ERa and
ERb), to produce both direct and indirect genomic effects.
The direct genomic effects are due to the interactions between
17b-estradiol and traditional cytoplasmic receptors followed
by the regulation of transcription, through interactions with
regulatory estrogen response elements of several genes. In
neurons, these genes include anti-apoptotic genes of the bcl-2
family, which are probably responsible for the neuroprotective
effects of 17b-estradiol observed in a number of models
of neuronal death. In astrocytes, genes include GFAP
(downregulated) and laminin (upregulated), which might be
involved in the sprouting responses observed following
lesions, and in normal astrocyte activation observed in brains
from old animals (Kohama et al., 1995). The indirect, non-
genomic actions of 17b-estradiol are believed to be mediated
through plasma membrane-associated ERs, whose actions are
associated with the activation of various protein-kinase cas-
cades (Losel and Wehling, 2003). Subsequent ‘non-genomic
to genomic signaling’ pathways of 17b-estradiol’s effects might
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be linked to the stimulation of the phosphoinositol-3 (PI3)
kinase/Akt system (Datta et al., 1999; Simoncini et al., 2000)
and/or of a G protein, and/or of Src tyrosine kinase and extra-
cellular signal-regulated kinase (ERK)/MAP kinase pathways
(reviewed in Bjornstrom and Sjoberg, 2005; Singh et al., 2000).
The MAP kinase pathway occupies a central place in the
regulation of synaptic plasticity (Mazzucchelli and Brambilla,
2000; Sweatt, 2001). Pharmacological manipulations directed
at blocking this pathway produce consistent impairments in
synaptic plasticity, and learning and memory, and this path-
way is activated with LTP-inducing tetanus and in different
learning paradigms (Brambilla et al., 1997; Berman et al., 1998;
Blum et al., 1999; Selcher et al., 1999). We have shown that
endogenous estrogen levels in cycling female rats produce
a tonic phosphorylation/activation of ERK2/MAP kinase (Bi
et al., 2001). In addition, we have shown that this activation
of the MAP kinase pathway is linked to the regulation of
glutamate ionotropic receptors and might be involved in
the ‘cognitive enhancing’ effects of 17b-estradiol. Indeed, the
acute, estrogen-mediated enhancement of LTP is mediated by
activation of a src tyrosine kinase pathway (Bi et al., 2000).
Thus, acute application of the src inhibitor PP2 in the
perfusing medium of hippocampal slices from adult male rats
abolishes the estrogen-mediated enhancement of both synap-
tic transmission and of LTP, but has no effect on LTP itself
(Fig. 5). Similarly, this pathway might also be involved in the
neuroprotective effects of 17b-estradiol because MAP kinase
inhibitors consistently block the neuroprotective effects of
17b-estradiol in several models of neurodegeneration. More-
over, growth factors and other factors providing neuro-
protection, such as PDGF, also use the MAP kinase pathway
for their neuroprotective effects.
Interestingly, it appears that ERa stimulation is crucial for
the neuroprotective effect of estrogen because 17b-estradiol
does not protect ERa-knock-out mice against ischemia-
induced neuronal damage (Dubal et al., 2001). Furthermore,
recent results obtained from the same knock-out mice suggest
the possible existence of novel 17b-estradiol receptors that are
responsible for the activation of the ERK/MAP kinase pathway
(Singh et al., 2000). These results indicate that several steps
described in Fig. 9 remain to be elucidated.
Concluding remarks
The studies described here establish several fundamental char-
acteristics of the effects of estrogen on synaptic transmission
in the mammalian CNS. Estrogen acts rapidly via presumed
membrane mechanisms to enhance both NMDA and AMPA
receptor/channel responses elicited by glutamate released from
excitatory presynaptic terminals.
17b-estradiol also markedly enhances hippocampal LTP in
CA1 neurons of adult, male rats. The enhancement of LTP after
acute application of 17b-estradiol is caused by increases in
NMDA-receptor and AMPA-receptor functions. Both possi-
bilities are consistent with intracellular data. Changes in estro-
gen levels in cycling female rats also correlate with changes in
synaptic plasticity, measured by changes in LTP magnitude.
This finding indicates a mechanism by which natural fluctua-
tions in endogenous hormone levels can impact a cellular
model associated with important aspects of learning and/or
memory storage in the mammalian CNS.
To the extent that LTP is a mechanism involved in processes
of coding and storage of information (i.e. in memory forma-
tion), estrogen appears to enhance these processes. Indeed, the
estrogen enhancement of LTP indicates a possible mechanism
by which estrogen exerts facilitatory effects on memory pro-
cesses in humans. Clinical evidence indicates that estrogenic
steroids enhance cognitive functions in humans, particularly
in postmenopausal women (Henderson, 1997; Kawas et al.,
1997; Henderson, 2000). However, prospective observational
studies do not find a protective effect of estrogen on either
cognition and the incidence of dementia (Barrett-Conner and
Kritz-Silverstein, 1993; Matthews et al., 1999). Understanding
the mechanisms that underlie the age-related changes in the
Fig. 9. General hypotheses that link estrogen/testosterone with the MAPK/ERK pathway, NMDA receptors and synaptic plasticity in brain.
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effects of estrogen will provide a significant advance in under-
standing of the mechanisms that are involved in the decline in
cognitive function with aging.
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